1-5 of 5
Stelios Kasikis
Close
Sort by
Journal Articles

The MAGIC algorithm probability predicts treatment response and long-term outcomes to second-line therapy for acute GVHD

Zachariah DeFilipp, Haesook T. Kim, Nikolaos Spyrou, Nikolaos Katsivelos, Steven Kowalyk, Gilbert Eng, Stelios Kasikis, Rahnuma Beheshti, Janna Baez, Yu Akahoshi, Francis Ayuk, Hannah Choe, Aaron Etra, Stephan A. Grupp, Elizabeth O. Hexner, William J. Hogan, Carrie L. Kitko, Muna Qayed, Ran Reshef, Ingrid Vasova, Robert Zeiser, Rachel Young, Ernst Holler, James L. M. Ferrara, Ryotaro Nakamura, John E. Levine, Yi-Bin Chen
Journal: Blood Advances
Blood Adv (2024) 8 (13): 3488–3496.
https://doi.org/10.1182/bloodadvances.2024012561
Published: 2024
Includes: Supplemental data
Journal Articles

Flares of acute graft-versus-host disease: a Mount Sinai Acute GVHD International Consortium analysis

Yu Akahoshi, Nikolaos Spyrou, Matthias Hoepting, Paibel Aguayo-Hiraldo, Francis Ayuk, Chantiya Chanswangphuwana, Hannah K. Choe, Matthias Eder, Aaron M. Etra, Stephan A. Grupp, Elizabeth O. Hexner, William J. Hogan, Carrie L. Kitko, Sabrina Kraus, Monzr M. Al Malki, Pietro Merli, Muna Qayed, Ran Reshef, Tal Schechter, Evelyn Ullrich, Ingrid Vasova, Matthias Wölfl, Robert Zeiser, Janna Baez, Rahnuma Beheshti, Gilbert Eng, Sigrun Gleich, Stelios Kasikis, Nikolaos Katsivelos, Steven Kowalyk, George Morales, Rachel Young, Zachariah DeFilipp, James L. M. Ferrara, John E. Levine, Ryotaro Nakamura
Journal: Blood Advances
Blood Adv (2024) 8 (8): 2047–2057.
https://doi.org/10.1182/bloodadvances.2023012091
Published: 2024
Includes: Supplemental data
Journal Articles

Phase 2 study of natalizumab plus standard corticosteroid treatment for high-risk acute graft-versus-host disease

Clinical Trials & Observations
Monzr M. Al Malki, Kaitlyn London, Janna Baez, Yu Akahoshi, William J. Hogan, Aaron Etra, Hannah Choe, Elizabeth Hexner, Amelia Langston, Sunil Abhyankar, Doris M. Ponce, Zachariah DeFilipp, Carrie L. Kitko, Kehinde Adekola, Ran Reshef, Francis Ayuk, Alexandra Capellini, Chantiya Chanswangphuwana, Matthias Eder, Gilbert Eng, Isha Gandhi, Stephan Grupp, Sigrun Gleich, Ernst Holler, Nora Rebeka Javorniczky, Stelios Kasikis, Steven Kowalyk, George Morales, Umut Özbek, Wolf Rösler, Nikolaos Spyrou, Gregory Yanik, Rachel Young, Yi-Bin Chen, Ryotaro Nakamura, James L. M. Ferrara, John E. Levine
Journal: Blood Advances
Blood Adv (2023) 7 (17): 5189–5198.
https://doi.org/10.1182/bloodadvances.2023009853
Published: 2023
Includes: Supplemental data
Journal Articles

Biomarker-guided preemption of steroid-refractory graft-versus-host disease with α-1-antitrypsin

Clinical Trials & Observations
Stephanie C. Gergoudis, Zachariah DeFilipp, Umut Özbek, Karamjeet S. Sandhu, Aaron M. Etra, Hannah K. Choe, Carrie L. Kitko, Francis Ayuk, Mina Aziz, Janna Baez, Kaitlyn Ben-David, Udomsak Bunworasate, Isha Gandhi, Elizabeth O. Hexner, William J. Hogan, Ernst Holler, Stelios Kasikis, Steven M. Kowalyk, Jung-Yi Lin, Pietro Merli, George Morales, Ryotaro Nakamura, Ran Reshef, Wolf Rösler, Hrishikesh Srinagesh, Rachel Young, Yi-Bin Chen, James L. M. Ferrara, John E. Levine
Journal: Blood Advances
Blood Adv (2020) 4 (24): 6098–6105.
https://doi.org/10.1182/bloodadvances.2020003336
Published: 2020
Includes: Supplemental data
Journal Articles

The MAGIC algorithm probability is a validated response biomarker of treatment of acute graft-versus-host disease

Clinical Trials & Observations
Hrishikesh K. Srinagesh, Umut Özbek, Urvi Kapoor, Francis Ayuk, Mina Aziz, Kaitlyn Ben-David, Hannah K. Choe, Zachariah DeFilipp, Aaron Etra, Stephan A. Grupp, Matthew J. Hartwell, Elizabeth O. Hexner, William J. Hogan, Alexander B. Karol, Stelios Kasikis, Carrie L. Kitko, Steven Kowalyk, Jung-Yi Lin, Hannah Major-Monfried, Stephan Mielke, Pietro Merli, George Morales, Rainer Ordemann, Michael A. Pulsipher, Muna Qayed, Pavan Reddy, Ran Reshef, Wolf Rösler, Karamjeet S. Sandhu, Tal Schechter, Jay Shah, Keith Sigel, Daniela Weber, Matthias Wölfl, Kitsada Wudhikarn, Rachel Young, John E. Levine, James L. M. Ferrara
Journal: Blood Advances
Blood Adv (2019) 3 (23): 4034–4042.
https://doi.org/10.1182/bloodadvances.2019000791
Published: 2019
Includes: Supplemental data